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Abstract 
Treatment discontinuations are an important issue in IVF programmes. In the French 
context, financial constraint does not intervene in discontinuation until older ages. 
This study examined treatment discontinuation in IVF programmes, according to the 
woman’s age and when there is no financial burden for couples. Medical records 
were collected for 3037 women who began their IVF programme between 1998 and 
2002 in two French IVF units. Up to four attempts were taken into consideration. 
Cumulative success (delivery) rates were calculated, as well as discontinuation rates. 
Multiple imputation was applied to estimate a theoretical cumulative success rate as 
if no woman discontinued treatment before the end of the IVF programme without 
delivering. Cumulative discontinuation rates at the end of the IVF programme 
increased with the woman’s age (41% for age<35, 56% for age 35–39, 80% for age 
≥40). The benefit in terms of delivery rates of pursuing treatment would be smaller for 
older women (~10% for age<35, 7% for age 35–39, 4% for age ≥40). Even when 
treatment is reimbursed, the discontinuation rate is high for older women, suggesting 
that the strong decrease in success rate with age induces older women to 
discontinue. 
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Introduction 
Since the middle of the twentieth century, epidemiologists and demographers have 
presented numerous results showing that the increasing age of a woman causes a 
decline in the biological ability to give birth to a child, i.e. fecundity (Henry 1961; 
Tietze 1957). These studies estimated that the age for the start of the fall in the 
probability of conception lay within the age range 31-35 years (Schwartz and Mayaux 
1982; van Noord-Zaadstra et al. 1991). 
A similar age effect has been shown for women undergoing in vitro fertilization 
(IVF). A decrease in the live birth rate per cycle started has been demonstrated in 
older women (Templeton et al. 1996). In particular, the success rate was highest for 
women aged between 25 and 30 and declined sharply after age 35.  
In the light of some recent studies, it seems interesting to consider IVF 
success not only in relation to each attempt, but also throughout the entire IVF 
program consisting of several successive attempts (Land et al. 1997; Witsenburg et 
al. 2005). Witsenburg et al. carried out a cohort study in two centers in The 
Netherlands that included 1456 patients starting IVF treatment between 1996 and 
2000 (Witsenburg, Dieben et al. 2005). They showed that although both centers had 
the same live birth rate per cycle (24%), their cumulative live birth rate differed 
significantly (59% vs. 49%). This was explained by the lower number of cycles 
undergone by the patient (due to a higher discontinuation rate) in the center with the 
lower cumulative success rate.  
Treatment discontinuations are an important issue in IVF programs, as the 
proportion of women discontinuing treatment before having a child is very high. Land 
et al. reported a cumulative drop-out rate of 62% after the three cycles that are 
reimbursed by health insurance in The Netherlands (Land et al. 1997), while La 
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Rochebrochard et al. reported this cumulative drop-out rate to be 46% and 58% at 
the end of the fourth and last reimbursed cycle in two French IVF units (La 
Rochebrochard (de) et al. 2008).  
Previous work suggests that the women who discontinue the IVF program may 
have a poorer prognosis of success than those who persevere (Sharma et al. 2002). 
In this context, life-table analysis has been shown to overestimate success rates 
(Daya 2005; Land et al. 1997; Witsenburg, Dieben et al. 2005), and so is considered 
as an “optimistic” estimation. Conversely, methods considering that patients who 
discontinue IVF have no chance of success lead to “conservative” estimations 
(Malizia et al. 2009). Various alternative methods have been developed to give a 
better estimate (Olivius et al. 2002; Soullier et al. 2008; Stolwijk et al. 2000). A 
possible solution would be to include the reason for discontinuation in the estimation 
of the cumulative success rate. The problem is that discontinuation of treatment is a 
matter of not deciding to continue, rather than deciding not to continue. It is defined a 
posteriori, when the women did not return to the IVF unit after a long period. Thus, 
the reason for discontinuation is not entered in the medical records and can be hard 
to determine. To study the reason for discontinuation, questionnaires must be sent to 
the women years after their last IVF attempt (Olivius et al. 2004; Rajkhowa et al. 
2006). When we wish to estimate the cumulative success rate, it is important to take 
into account discontinuations of treatment. However, it is not the reason for 
discontinuation which is most important, but the chances of success that women who 
discontinued would have had. The two may be linked as women discontinuing for a 
medical reason are likely to have had poor chances of success if they had continued. 
However, when the objective is to estimate the success rate, data focus on medical 
records and do not clarify the reason for discontinuation. Rather, they provide 
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variables that are linked with both success and discontinuation and can be used to 
compare women discontinuing and women continuing, as well as to make inferences 
on the chances of success that women who discontinued would otherwise have had. 
This appears to be a promising method of providing a better estimation of the IVF 
success rate than that obtained with “optimistic” or “conservative” methods (Malizia et 
al. 2009). 
The French social security system reimburses up to four IVF attempts to all 
couples until the woman is 43 years old. In this context, financial constraint does not 
intervene in discontinuation until older ages. 
We aimed to examine treatment discontinuation in IVF programs, according to 
the woman’s age and when there is no financial burden for couples. 
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Materials and methods 
The Institutional Review Board (CNIL) approved the project in September 2005. 
Population and methods have been detailed in a previous article (Soullier et al. 2008) 
and are briefly described below. 
 
 
Materials 
Data were provided by two French IVF units (Cochin in Paris and Clermont-
Ferrand, a medium-sized city in the center of France). All 3037 women beginning an 
IVF program between 1998 and 2002 in these two units were included. Data were 
collected from medical records and concerned all conventional IVF procedures and 
intracytoplasmic sperm injections (ICSI) undergone by the woman in the IVF unit, as 
well as data on frozen embryo transfers (FET) up to 2005. Data were collected until 
the woman’s fourth attempt, four being the number of attempts which is refunded by 
the French social security system. 
 
Definitions 
An IVF program was therefore defined as a maximum of four successive attempts 
undergone by the woman in the IVF unit. An attempt was defined as an aspiration, 
i.e. an oocyte pick-up from the patient (cycles cancelled before oocyte retrieval were 
not included). Success of an attempt was defined as a delivery resulting from fresh or 
frozen embryo transfer. Only the first delivery was considered. Discontinuation of 
treatment was defined as no subsequent attempt in the IVF unit for at least two years 
at the time of data acquisition, whatever the reason for discontinuation (decision to 
stop IVF treatment, relocation to another area, decision to pursue treatment in 
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another IVF center, etc). Age was defined at the beginning of the IVF program and 
was considered as a categorical variable divided into 5 groups: <25, [25 – 29], [30 – 
34], [35 – 39], and ≥40 years. 
 
Methods 
The observed cumulative delivery rate corresponded to the percentage of 
women entering the IVF unit and delivering during the IVF program. 
The cumulative discontinuation rate corresponded to the proportion of women 
discontinuing treatment before the end of the IVF program without delivering 
expressed as  a percentage of the women entering the IVF unit.. 
 
To evaluate the efficiency of the IVF technique, the theoretical cumulative 
delivery rate was calculated. This is the delivery rate which would be achieved if no 
woman discontinued treatment before the end of the IVF program. It was calculated 
by reconstituting a whole program for women who discontinue treatment as if they 
had in fact continued. Outcomes of attempts posterior to discontinuation were treated 
as missing and were estimated with multiple imputation (MI). The MI method consists 
of replacing each missing value by a set of plausible values in order to take into 
account the uncertainty about the correct value to impute. This method has been 
presented in detail elsewhere (Soullier et al. 2008; Soullier et al. 2010). The MI 
estimation was made using the known characteristics of women and of their previous 
aspirations: IVF unit, woman’s age, number of oocytes retrieved and total number of 
embryos (defined as the sum of the number of transferred embryos and the number 
of frozen embryos). Following Rubin’s recommendations, we made 5 imputations by 
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attempt (Rubin 1996). Multiple imputation was carried out using the SAS MI 
procedure (SAS/STAT® 9.1 User’s Guide. Cary, NC: SAS Institute Inc., 2004). 
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Results 
Of the 3037 women included, 716 (24%) were aged between 25 and 29 years 
at the beginning of their IVF program, 1215 (40%) were aged between 30 and 34 
years and 807 (27%) were aged between 35 and 39 years. The younger and older 
age groups were much smaller: at the beginning of the IVF program, 80 women (3%) 
were aged less than 25 years and 219 (7%) were aged ≥40 years. Median age at the 
beginning of the program was 32 years. On average, women were aged 33 years at 
the first and second attempts, 34 years at the third attempt and 35 at the fourth 
attempt. 
The decrease in observed delivery rates with the woman’s age is shown in 
Figure 1 (solid line). The three groups of women starting an IVF program before age 
35 had similar chances of delivery. In older women, the observed cumulative delivery 
rate decreased for age 35-39 and declined sharply for age ≥40. These observed 
delivery rates at ages 35-39 and ≥40 differed significantly both from each other and 
from those of the age groups <35 years (p-values < 0.03). 
On the other hand, cumulative discontinuation rates at the end of the IVF 
program increased with the woman’s age (Table 1). Indeed, 41% of women starting 
an IVF program before age 35 years discontinued treatment before completion 
without delivering. This proportion increased to 56% for women starting a program 
between age 35 and 39 and was twice as high (80%) for women aged ≥40 at the 
beginning of the IVF program. Concerning the time of discontinuation, half of all 
women discontinuing treatment did so after the first attempt, 32% after the second 
and 18% after the third. This distribution was similar in the five age groups. 
The theoretical cumulative delivery rate estimated what the cumulative 
delivery rates would be if no woman discontinued before the end of the IVF program 
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without delivering (Figure 1). This would increase the chances of delivery for women 
starting IVF before age 35 years by about 10%. Thus, younger women would have a 
more than 50% chance of delivery during the IVF program if none of them 
discontinued treatment. For women starting IVF when older than 35 years, the 
increase would be smaller: 7% for women starting between age 35 and 39, and 4% 
for women starting at 40 years or later. Overall, the delivery rate would increase from 
37% to 46% if no woman discontinued treatment before the end of the IVF program 
without delivering. 
Differences were also noted in the time elapsing between successive attempts 
according to the woman’s age. On average, the time elapsing since the beginning of 
the IVF program was 1.0 year at the time of the second attempt, 1.8 years at the third 
attempt and 2.6 years at the fourth attempt (Table 2). However, the intervals between 
attempts were shorter for older age groups. Women beginning an IVF program 
before age 35 completed the fourth attempt approximately 2.7 years later, whereas 
women starting a program at age ≥40 took 1 year less to complete a program of four 
attempts (1.7 years). Carrying out the same analysis but including only the women 
who did not have frozen embryo transfers between aspirations, the same significant 
trend was observed at each attempt (p-values < 0.002). This result was therefore not 
due to a greater number of frozen embryo transfers for the younger women.  
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Discussion 
Studying the effect of the woman’s age on discontinuation of IVF treatment is 
a new and important topic. It is particularly interesting to study this issue in the 
French context, where four attempts are reimbursed by the French social security 
system for all women aged less than 43 years. Indeed, financial burden did not 
intervene in the decision to discontinue. We observed that the cumulative 
discontinuation rate was high and that it strongly increased with the woman’s age. 
We also noted a strong decrease in cumulative IVF success rates with the 
woman’s age: from 44% at 25-29 years to 14% at over 40 years old. This decrease 
may be even greater if not only oocyte pick-up cycles but also all cycles where 
women started stimulation are included. In our study, this decrease can be explained 
both by a decrease in delivery rates following embryo transfer and by a decrease in 
the number of frozen embryo transfers following an IVF attempt. Indeed, after the first 
IVF attempt, 40% of women aged <35 years who did not obtain a delivery after fresh 
embryo transfer had at least one frozen embryo transfer, but this proportion 
decreased to 29% among women aged 35-39 years and 18% among those aged 40 
years and older. In our analysis, the effect of the center’s frozen embryo policy was 
controlled by including a center effect in the imputation model. 
 
Both women and physicians are well aware of this decrease. Two results 
suggested that IVF success rates were being taken into account by the women who 
discontinued. First, the difference between the theoretical and the observed 
cumulative delivery rates was smaller for older women than for younger women. The 
theoretical cumulative delivery rate - the rate as if no woman discontinued unless she 
delivered - was estimated using multiple imputation based on variables 
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characterizing the main biological factors explaining IVF success and discontinuation 
for medical reasons (Sharma et al. 2002; Soullier et al. 2008; Templeton et al. 1996). 
The small difference between the observed and the theoretical cumulative success 
rates for older women might then suggest that most of these discontinuations were 
due to poor chances of success. Second, older women completed an IVF program 
more quickly than younger women: women aged <35 when they started the IVF 
program completed the whole program in almost three years, whereas women aged 
between 35 and 39 completed it in two years and women aged ≥40 in a year and a 
half. This difference was not due to a greater number of frozen embryo transfers 
undergone by the younger women. This could reflect the fact that physicians and/or 
women are aware that IVF efficiency decreases markedly after age 35. Therefore, 
physicians and their patients may be more likely to conduct IVF cycles in rapid 
succession, to diminish the effect of further age-related decline on IVF success. The 
hypothesis that women beginning an IVF program after age 35 received more rapid 
treatment has been suggested in a study in a French unit (Tain 2002). Such a 
possibility deserves more detailed research. 
In a brand-new perspective, this work suggests that when financial constraint 
does not intervene, another process leads older women to discontinue treatment. 
Further research should be done to determine how this process originates: does the 
woman/couple make the decision to discontinue or do the medical staff strongly 
recommend it? In the latter case, the couple may consider pursuing treatment in 
another IVF unit. Further work should address the reasons and consequences of the 
decision to discontinue IVF treatment. Moreover, it will be important to develop these 
results by examining how cycles cancelled before oocyte pick-up affect the treatment 
discontinuation process. These cancelled cycles could represent 10% to 15% of all 
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cycles (Min et al. 2004) and center policies regarding cancellation of IVF treatment 
before oocyte pick-up may vary. This issue could not be dealt in the current study as 
data on all cycles where women started stimulation were not collected. 
 
In a context of state reimbursement for all, the increase in discontinuation 
rates with the woman’s age suggests that IVF care self-regulates. Even when the IVF 
attempts are reimbursed, the discontinuation rate is very high for older women, 
suggesting that the strong decrease in success rate with age induces them to 
discontinue treatment.  
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Table 1. Cumulative discontinuation rates at the end of the IVF program 
according to the woman’s age at the beginning of the program 
Woman’s age (years) N 
Cumulative discontinuation 
ratea % 
< 25 80   41   
25 - 29 716  41  
30 - 34 1215  41  
35 - 39 807  56  
≥ 40 219  80  
Overall 3037   48   
a Proportion of women discontinuing treatment before the end of the IVF 
program without delivering expressed as  a percentage of the women 
entering the IVF unit 
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Table 2. Length of time (in years) between the beginning of the IVF program 
and subsequent attempts, according to the woman’s age at the beginning of 
the program 
Woman’s age 
(years) 
Length of time (years) since the beginning of the IVF 
program 
Attempt 2   Attempt 3   Attempt 4 
N Mean  N Mean  N Mean 
< 25 49   1.1     20   2.0     12   2.7   
25 - 29 433  1.1   230  2.0   108  2.8  
30 - 34 759  1.0   424  1.8   219  2.7  
35 - 39 443  0.8   221  1.5   118  2.2  
≥ 40 104  0.6   38  1.2   12  1.7  
p-value for trend <0.0001  <0.0001  <0.0001 
 
 20 
Figure 1. Cumulative delivery rates according to the woman’s age at the 
beginning of the IVF programme. Triangles with solid line = observed rates; 
squares with dotted line = theoretical rates. 
 
 
Data for figure 1 
Age at the first 
attempt (years) 
N 
Observed 
rates 
Theoretical 
rates 
< 25 80 40.00 49.59 
25 - 29 716 44.00 55.94 
30 - 34 1215 41.98 51.46 
35 - 39 807 27.88 35.19 
≥ 40 219 14.16 18.19 
Overall 3037 36.78 45.74 
 
